Nuwellis (NUWE) EBT Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,313.00 |
| Dec 31, 2025 | 77,642.00 |
| Sep 30, 2025 | 24,469.00 |
| Jun 30, 2025 | -51,706.00 |
| Mar 31, 2025 | 12,188.00 |
| Dec 31, 2024 | 74,448.00 |
| Sep 30, 2024 | 45,968.00 |
| Jun 30, 2024 | -8,796.00 |
| Mar 31, 2024 | 15,582.00 |
| Dec 31, 2023 | 6,785.00 |
| Sep 30, 2023 | 17,144.00 |
| Jun 30, 2023 | 14,686.00 |
| Mar 31, 2023 | 6,483.00 |
| Dec 31, 2022 | 139,893.00 |
| Sep 30, 2022 | 10,966.00 |
| Jun 30, 2022 | 9,079.00 |
| Mar 31, 2022 | -12,781.00 |
| Dec 31, 2021 | 12,585.00 |
| Sep 30, 2021 | 44,893.00 |
| Mar 31, 2020 | 1.17 Mn |
| Dec 31, 2019 | 343,922.00 |
| Sep 30, 2019 | 1.00 Mn |
| Mar 31, 2019 | 1.03 Mn |
| Sep 30, 2018 | 1.01 Mn |